Insider Stock Trading History of Xanthopoulos Kleanthis G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Xanthopoulos Kleanthis G since year 2005. The trader's CIK number is 1283304. At the time of this reporting, Xanthopoulos Kleanthis G is the Director of Zosano Pharma Corp . (stock ticker symbol ZSAN). See this page for all insider trading activities at Zosano Pharma Corp .

Note that in the past XANTHOPOULOS KLEANTHIS G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Xanthopoulos Kleanthis G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-19 ZSAN Zosano Pharma Corp Buy 15,920 1.32 21,014
2015-04-20 RGLS Regulus Therapeutics Inc. Sale 66,071 16.85 1,113,494
2015-04-21 RGLS Regulus Therapeutics Inc. Sale 60,000 17.73 1,063,980
2015-04-17 RGLS Regulus Therapeutics Inc. Option Ex 73,929 .38 28,093
2015-04-17 RGLS Regulus Therapeutics Inc. Sale 73,929 16.93 1,251,987
2015-04-20 RGLS Regulus Therapeutics Inc. Option Ex 66,071 .38 25,106
2015-04-21 RGLS Regulus Therapeutics Inc. Option Ex 60,000 .38 22,800
2015-03-05 RGLS Regulus Therapeutics Inc. Sale 89,230 20.44 1,823,771
2015-03-05 RGLS Regulus Therapeutics Inc. Option Ex 89,230 .38 33,907
2015-02-27 RGLS Regulus Therapeutics Inc. Sale 70 19.50 1,365
2015-02-27 RGLS Regulus Therapeutics Inc. Option Ex 70 .38 26
2015-01-30 RGLS Regulus Therapeutics Inc. Sale 3,300 19.50 64,350
2015-02-02 RGLS Regulus Therapeutics Inc. Sale 2,400 19.77 47,440
2015-01-30 RGLS Regulus Therapeutics Inc. Option Ex 3,300 .38 1,254
2015-02-02 RGLS Regulus Therapeutics Inc. Option Ex 2,400 .38 912
2015-01-29 RGLS Regulus Therapeutics Inc. Option Ex 60,000 .38 22,800
2015-01-28 RGLS Regulus Therapeutics Inc. Option Ex 85,000 .38 32,300
2015-01-29 RGLS Regulus Therapeutics Inc. Sale 60,000 18.08 1,085,040
2015-01-28 RGLS Regulus Therapeutics Inc. Sale 85,000 18.33 1,557,710
2014-10-29 RGLS Regulus Therapeutics Inc. Sale 3,505 19.62 68,757
2014-10-29 RGLS Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-10-17 RGLS Regulus Therapeutics Inc. Option Ex 400 .38 152
2014-10-17 RGLS Regulus Therapeutics Inc. Sale 400 7.04 2,816
2014-10-20 RGLS Regulus Therapeutics Inc. Option Ex 300 .38 114
2014-10-20 RGLS Regulus Therapeutics Inc. Sale 300 7.00 2,100
2014-10-14 RGLS Regulus Therapeutics Inc. Option Ex 400 .38 152
2014-10-09 RGLS Regulus Therapeutics Inc. Sale 105 7.00 735
2014-10-09 RGLS Regulus Therapeutics Inc. Option Ex 105 .38 39
2014-10-14 RGLS Regulus Therapeutics Inc. Sale 400 7.00 2,800
2014-09-30 RGLS Regulus Therapeutics Inc. Sale 2,300 7.02 16,136
2014-09-30 RGLS Regulus Therapeutics Inc. Option Ex 2,300 .38 874
2014-08-28 "RGLS" Regulus Therapeutics Inc. Sale 3,505 7.06 24,755
2014-08-28 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-08-05 "RGLS" Regulus Therapeutics Inc. Sale 3,505 7.06 24,738
2014-08-05 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-07-01 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-07-01 "RGLS" Regulus Therapeutics Inc. Sale 3,505 8.11 28,425
2014-06-09 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-06-09 "RGLS" Regulus Therapeutics Inc. Sale 3,505 7.14 25,018
2014-05-28 "RGLS" Regulus Therapeutics Inc. Option Ex 875 .38 332
2014-05-27 "RGLS" Regulus Therapeutics Inc. Sale 1,743 7.00 12,202
2014-05-29 "RGLS" Regulus Therapeutics Inc. Option Ex 887 .38 337
2014-05-28 "RGLS" Regulus Therapeutics Inc. Sale 875 7.00 6,125
2014-05-29 "RGLS" Regulus Therapeutics Inc. Sale 887 7.00 6,209
2014-05-27 "RGLS" Regulus Therapeutics Inc. Option Ex 1,743 .38 662
2014-03-06 "RGLS" Regulus Therapeutics Inc. Sale 3,505 7.60 26,623
2014-03-06 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-03-06 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-03-06 "RGLS" Regulus Therapeutics Inc. Sale 3,505 11.35 39,778
2014-02-05 "RGLS" Regulus Therapeutics Inc. Sale 3,505 8.40 29,438
2014-02-05 "RGLS" Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-01-02 RGLS Regulus Therapeutics Inc. Option Ex 3,505 .38 1,331
2014-01-02 RGLS Regulus Therapeutics Inc. Sale 3,505 7.25 25,407
2013-12-26 APRI Nexmed Inc Sale 17,184 2.55 43,819
2013-06-21 APRI Nexmed Inc Sale 2,864 2.52 7,217
2013-05-21 APRI Nexmed Inc Sale 2,864 3.36 9,611
2013-04-22 APRI Nexmed Inc Sale 2,864 2.63 7,523
2013-03-21 APRI Nexmed Inc Sale 2,864 2.50 7,160
2012-09-28 APRI Nexmed Inc Sale 3,125 3.25 10,159
2012-08-15 APRI Nexmed Inc Sale 12,500 3.02 37,687
2007-08-16 ANDS Anadys Pharmaceuticals Inc Buy 6,500 2.15 13,955
2006-11-14 ANDS Anadys Pharmaceuticals Inc Sale 100 5.00 500
2006-05-15 ANDS Anadys Pharmaceuticals Inc Sale 5,000 10.49 52,440
2006-04-17 ANDS Anadys Pharmaceuticals Inc Sale 5,000 14.82 74,125
2006-03-20 ANDS Anadys Pharmaceuticals Inc Sale 5,000 15.36 76,800
2006-03-07 ANDS Anadys Pharmaceuticals Inc Option Ex 30,000 2.95 88,500
2006-03-07 ANDS Anadys Pharmaceuticals Inc Sale 30,000 14.67 440,100
2006-03-07 ANDS Anadys Pharmaceuticals Inc Option Ex 30,000 2.95 88,500
2006-03-07 ANDS Anadys Pharmaceuticals Inc Sale 30,000 14.67 440,100
2006-02-28 ANDS Anadys Pharmaceuticals Inc Sale 6,141 12.99 79,747
2006-02-21 ANDS Anadys Pharmaceuticals Inc Sale 5,000 11.81 59,050
2006-01-17 ANDS Anadys Pharmaceuticals Inc Sale 5,000 11.03 55,134
2005-12-19 ANDS Anadys Pharmaceuticals Inc Sale 5,000 8.15 40,740
2005-11-21 ANDS Anadys Pharmaceuticals Inc Sale 5,000 10.58 52,920
2005-10-17 ANDS Anadys Pharmaceuticals Inc Sale 5,000 10.90 54,490
2005-09-19 ANDS Anadys Pharmaceuticals Inc Sale 5,000 13.38 66,895
2005-08-15 ANDS Anadys Pharmaceuticals Inc Sale 5,000 12.84 64,185
2005-07-18 ANDS Anadys Pharmaceuticals Inc Sale 5,000 11.24 56,220
2005-06-21 ANDS Anadys Pharmaceuticals Inc Sale 5,000 8.62 43,105

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Xanthopoulos Kleanthis G (Director of Zosano Pharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.